Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AMGEN INC.

(AMGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
CommuniquÚs de presse de la sociÚtÚ AMGEN INC.
01/14AMGEN : Teneobio Acquisition Adds Talent and New Types of Antibodies to Amgen
PU
01/13TEZSPIRE™ (TEZEPELUMAB-EKKO) NOW AVAILABLE IN THE UNITED STATES FOR THE TREATMENT..
PR
01/12AMGEN : Going Beyond Skin Deep When Managing Plaque Psoriasis
PU
01/11Amgen - EUROPEAN COMMISSION APPROVES LUMYKRAS (SOTORASIB) FOR PATIENTS WITH KRAS G12C-M..
AQ
01/11Amgen and arrakis therapeutics announce multi-target collaboration to identify novel rn..
PR
01/10Amgen and biolabs la at the lundquist institute announce that karma biotechnologies wil..
PR
01/07Amgen Petitions For Certiorari To Reconsider Enablement Of Genus Claims
AQ
01/06Amgen to present at the 40th annual j.p. morgan healthcare conference
PR
01/06Amgen and generate biomedicines announce multi-target, multi-modality research collabor..
PR
2021Amgen to present at the goldman sachs 14th annual healthcare ceos unscripted conference
PR
2021Fda approves otezla« (apremilast) for the treatment of adult patients with plaque psori..
PR
2021Fda approves tezspire (tezepelumab-ekko) in the u.s. for severe asthma
AQ
2021AMGEN : Behind the Discovery of a New Homegrown Molecule for Severe Asthma
PU
2021AMGEN : A Hashtag For What Needs to Be Said About Asthma
PU
2021SEVERE ASTHMA AND TSLP : Fast Facts
PU
2021FDA APPROVES TEZSPIRE™ (TEZEPELUMAB-EKKO) IN THE U.S. FOR SEVERE ASTHMA
PR
2021AMGEN : Accelerating R&D to Speed Medicines to Patients
PU
2021FROM PRISON TO PHD : The Journey of Education and Redemption
PU
2021AMGEN : Advancing All Angles of Care for Cancer Patients
PU
2021AMGEN : Innovation▓ with Jane Parnes and Nina Tandon
PU
2021CANDID CONVERSATIONS : Ability Bettered Through Leadership and Education (ABLE)
PU
2021Amgen Announces New Data Being Presented At ASH 2021
AQ
2021Amgen Announces 10% Increase in 2022 First Quarter Dividend
AQ
2021AMGEN : Bradway Hails Amgen's Progress Against 'Undruggable' Disease Targets at Two Health..
PU
2021Amgen Announces 10% Increase In 2022 First Quarter Dividend
PR
2021Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LL..
AQ
2021Amgen Announces Positive Top-Line Results From Otezla« (apremilast) Phase 3 DISCREET St..
PR
2021AMGEN : Every Patient Counts, Every Story Matters
PU
2021Amgen Named To Dow Jones Sustainability World Index For Eighth Consecutive Year
PR
2021Amgen To Present At The 2021 Evercore ISI Healthcare Conference
PR
2021Amgen To Present At The 2021 Piper Sandler Healthcare Conference
PR
2021AMGEN : In a First for Industry, Murielle Veniant-Ellison Honored With 2022 Havel Lectures..
PU
2021AMGEN : Supporting Access to Nutritious Foods in Amgen's Community
PU
2021AMGEN : A New Way to Connect Psoriatic Disease Patients with Healthcare Providers
PU
2021Amgen Awards The Bath Institute of Rheumatic Diseases $25,000 Through UPLIFT Innovation..
PR
2021AMGEN : Leaders Join the Conversation at Financial Times Global Pharma and Biotech Confere..
PU
2021COVID-19 Accelerates Biopharmaceutical Innovation, Bradway Says at Annual Investor Conf..
PU
2021Amgen To Present At The 2021 Annual Cowen IO Summit
PR
2021What to Know About Biologic Medicines for Severe Asthma
PU
2021Successful Groundbreaking Ceremony for Amgen Ohio
PU
2021Amgen Begins Construction On New Biomanufacturing Plant In Central Ohio
PR
2021Amgen Featured in Video Series Highlighting Leading Innovators
PU
2021AMGEN INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
2021AMGEN REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS - Form 8-K
PU
2021AMGEN : Q3 Earnings Snapshot
AQ
2021Amgen Announces Webcast Of 2021 Third Quarter Financial Results
PR
2021Nina Parker on Breaking the Cycle of Asthma
PU
2021Building Healthcare System Resilience With Biosimilars
PU
2021Fortune and Great Place to Work« Name Amgen One of the World's Best Workplaces™ i..
PR
2021AMGEN : Announces 2021 Fourth Quarter Dividend
PR
2021AMGEN : Introducing Undruggable, a New Serial Podcast from Amgen R&D Exploring how Multisp..
PU
2021AMGEN : A Special Edition of Innovation2, brought to you by David and Jim Reese (Brothers2..
PU
2021AMGEN : Successfully Completes Acquisition Of Teneobio, Inc.
PR
2021AMGEN : Named One of the ‘World's Best Workplaces'
PU
2021AMGEN : Third-Longest Tenured Employee Leaves a Legacy After 35 Years of Service
PU
2021AMGEN : “Green” Chemistry Makes Pharmaceutical Manufacturing Better for the Pl..
PU
2021AMGEN : Working Together to Improve Public Health Outcomes
PU
2021AMGEN : Discover What Fosters Innovation and Drives Change Through Amgen's Innovation2 Ser..
PU
2021AMGEN : Announces New LUMAKRAS™ (sotorasib) Combination Data From Phase 1b CodeBreaK..
PR
2021AMGEN : and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel ..
PR
2021AMGEN : Presentation on Inflammation Portfolio from EADV
PU
2021GLOBAL DIVERSITY AWARENESS MONTH : Our Differences Lead to Better Science
PU
2021AMGEN : To Webcast Investor Call At EADV 2021
PR
2021CANDID CONVERSATIONS : Amgen Latin Employee Network
PU
2021AMGEN : Exploring Climate Change and Lung Health
PU
2021AMGEN : FDA Approves Repatha« (evolocumab) In Pediatric Patients Age 10 And Older With Het..
PR
2021AMGEN : To Present At The 2021 Cantor Global Healthcare Conference
PR
2021AMGEN : Releases 8th Edition of Biosimilar Trends Report
PR
2021AMGEN : Investor Presentation September 2021
PU
2021AMGEN : Margaret Chu-Moyer Honored with Prestigious Portoghese Lectureship
PU
2021AMGEN : Wins Patent Case on Otezla« (apremilast)
PR
2021AMGEN : Joins International Respiratory Coalition as Founding Member
PU
2021AMGEN : Celebrates 20 Years of Aranesp« (darbepoetin alfa) as a Treatment for Patients Wit..
PU
2021AMGEN : Diversity, Inclusion and Belonging at Amgen – A Progress Report
PU
2021AMGEN : Conference Call from ESMO Presentation
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on AMGEN INC.